# VITAL Rhythm Study

Study · id `cardio:ct-nct02178410` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02178410](<https://clinicaltrials.gov/study/NCT02178410>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02178410

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 25119 participants.

## Technical summary

Registry record NCT02178410. Randomized; triple masking; primary purpose prevention. Start 2012-10 (actual); primary completion 2027-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 25119 participants (enrolled count; ClinicalTrials.gov record NCT02178410, source copy `cardio:ctgov-nct02178410-2026-11-13`, retrieved 2026-11-18)
- Started: 2012-10 (actual) (ClinicalTrials.gov record NCT02178410, source copy `cardio:ctgov-nct02178410-2026-11-13`, retrieved 2026-11-18)
- Primary completion: 2027-10 (anticipated) (ClinicalTrials.gov record NCT02178410, source copy `cardio:ctgov-nct02178410-2026-11-13`, retrieved 2026-11-18)
- Completion: 2027-10 (anticipated) (ClinicalTrials.gov record NCT02178410, source copy `cardio:ctgov-nct02178410-2026-11-13`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT02178410, source copy `cardio:ctgov-nct02178410-2026-11-13`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02178410-2026-11-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: VITAL Rhythm Study
- Condition: Cardiovascular Disease
- Intervention (Dietary supplement): Vitamin D3
- Intervention (Drug): Omega-3 fatty acids (fish oil)
- Intervention (Dietary supplement): Fish oil placebo
- Intervention (Dietary supplement): Vitamin D3 placebo
- Lead sponsor: Brigham and Women's Hospital
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH
- Collaborator: Cedars-Sinai Medical Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Brigham and Women's Hospital (`cardio:org-brigham-and-women-s-hospital`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)
- Registry lists this organization as a collaborator: Cedars-Sinai Medical Center (`cardio:org-cedars-sinai-medical-center`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Sex Differences in Atrial Fibrillation Risk: The VITAL Rhythm Study (`cardio:pubmed-36044209`)
- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial (`cardio:pubmed-33724323`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 72be42e2cb41bbb12415ae3e21c724aee67a1c6d8c58d37b1a04dae5fd41c2a0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
